Other OTC - Delayed Quote • USD
Development Technologies Corp. (DVTC)
As of January 2 at 2:45 PM EST. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Daniel P. Kesonen | Chairman, CEO & Pres | -- | -- | -- |
| Mr. Robert Zerbe | Founder | -- | -- | -- |
| Mr. Robert Dombey | Founder | -- | -- | -- |
Development Technologies Corp.
4440 PGA Boulevard
Suite 308
Palm Beach Gardens, FL 33410
United States
- Sector:
- Financial Services
- Industry: Shell Companies
Description
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities. Pegasus Pharmaceuticals Inc. was founded in 1995 and is headquartered in Palm Beach Gardens, Florida.
Corporate Governance
Development Technologies Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Upcoming Events Information Not Available